Ziopharm Oncology
ZIOP
#8626
Rank
C$0.26 B
Marketcap
C$1.21
Share price
-0.88%
Change (1 day)
-75.39%
Change (1 year)

Earnings for Ziopharm Oncology (ZIOP)

Earnings in 2021 (TTM): -C$0.12 Billion

According to Ziopharm Oncology's latest financial reports the company's current earnings are C$3.73 Million. In 2020 the company made an earning of -C$0.12 Billion a decrease over its 2019 earnings that were of -C$80.5 Million.

Earnings history for Ziopharm Oncology from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-C$0.12 Billion0.6%
2020-C$0.12 Billion38.89%
2019-C$80.5 Million7.33%
2018-C$75 Million0.77%
2017-C$74.42 Million-67.64%
2016-C$0.23 Billion37.64%
2015-C$0.17 Billion176.1%
2014-C$60.52 Million-24.63%
2013-C$80.3 Million-43.51%
2012-C$0.15 Billion43.09%
2011-C$99.34 Million190.88%
2010-C$34.15 Million102.46%
2009-C$16.87 Million-52.68%
2008-C$35.65 Million-10.33%
2007-C$39.75 Million15.35%
2006-C$34.46 Million355.36%
2005-C$7.57 Million13788.35%
2004-C$0.06 Million9.27%
2003-C$0.05 Million-10.26%
2002-C$0.06 Million-59.35%
2001-C$0.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$12.48 B-10,154.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-C$0.71 Billion 465.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$12.97 B-10,548.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-C$3.83 Million-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA